Pay in 4 interest-free payments of $6.18 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
Phase Therapeutic range Weeks Weeks 17-20 Weekly Dose 9 mg Notes Phase 3 target dose for many TRIUMPH arms
The study led to the current Phase 3 trial (NCT05181137)) which began in November 2021 and, based on its estimated completion date, is anticipated to be ongoing
Some are within your control
As previously described, the roGFP probe is already partially oxidized under standard temperature conditions, which is due to a lower glutathione redox potential (Figure 3, Meyer et al., 2007)
The entire process can be accomplished in 12 steps with an overall yield of 2.6%, and the product is more than 90% pure without preparative chromatography
Consider: Monitoring diuretic needs during dose escalation or gastrointestinal symptoms Monitoring blood pressure closely if taking ACE inhibitors or ARBs Avoiding NSAIDs for routine pain management
US$ 20.37
US$ 27.28
US$ 22.50
